TNFRSF8 and peripheral T-cell lymphoma, not otherwise specified: Notably, the combination of brentuximab vedotin with CHP (cyclophosphamide, doxorubicin, and prednisone), substituting vincristine, has been demonstrated to significantly enhance both progression - free and overall survival in CD30 - expressing peripheral T - cell lymphomas when compared to conventional CHOP (33).